OPPORTUNITIES TO OPTIMIZE ANTIEPILEPTIC THERAPY WITH USE OF PHARMACOGENETIC BIOMARKERS

by T. V. Dokukina, M. V. Makhrov, I. V. Gaidukevich, A. A. Gilep, T. S. Golubeva, F. P. Khlebokazov, N. N. Misyuk, P. P. Korolevich
Published 2016-05-01

Evaluation of the effectiveness of electroconvulsive therapy in the treatment of psychosis in a patient with epilepsy. Clinical case

by T. V. Dokukina, F. P. Khlebokazov, I. I. Khvostova, N. N. Misyuk, K. A. Bondar, P. P. Korolevich, E. L. Slobina, I. S. Glavinskiy
Published 2021-07-01

Use of autologous mesenchymal stem cells in the combined treatment of symptomatic epilepsy

by F. P. Khlebokazov, T. V. Dokukina, N. Yu. Paramonova, S. I. Gotto, I. I. Khvostova, N. N. Misyuk, A. I. Martynenko, Е. L. Slobina, I. V. Shamruk
Published 2019-07-01

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING

by T. V. Dokukina, A. I. Startsev, M. V. Makhrov, I. V. Haidukevich, T. S. Golubeva, A. A. Gilep, E. A. Sheremet, I. V. Shamruk, A. S. Pinchuk, S. A. Marchuk, F. P. Khlebokazov, N. N. Misyuk
Published 2016-08-01

OUR EXPERIENCE IN APPLICATION OF AUTOLOGOUS BONE-MARROW-DERIVED MESENCHYMAL STEM CELLS FOR THERAPY OF PATIENTS WITH SYMPTOMATIC EPILEPSY

by F. P. Hlebokazov, T. V. Dоkukina, S. I. Ighnatenko, S. M. Кosmacheva, N. V. Goncharova, M. P. Potapnev, M. V. Makhrov, P. P. Korolevich, N. N. Misyuk, I. V. Grigorieva, S. A. Marchuk
Published 2016-05-01